Published in Gene Therapy Weekly, August 19th, 2004
The new QuantiGene human genome RNA profiling products will, according to the companies, provide accurate and precise measurement of gene-silencing experiments using small interfering RNA (siRNA). When used together, QuantiGene bDNA assays and SMARTpool siRNA products will allow researchers to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.